Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report

Psychological Medicine

Volumn 43, Issue 5, 2013, Pages 945-960

  Sung, S C ^a   Wisniewski, S R ^b   Balasubramani, G K ^b   Zisook, S ^c   Kurian, B ^d   Warden, D ^d   Trivedi, M H ^d   Rush, A J ^a  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Age of onset; chronic; depression; early onset; recurrent

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CYCLOHEXANOL DERIVATIVE; DRUG DERIVATIVE; MIANSERIN; MIRTAZAPINE; PLACEBO; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD ABUSE; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DRUG COMBINATION; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; ONSET AGE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SELF REPORT; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; STATISTICAL MODEL; STATISTICS; SUICIDAL IDEATION; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CHILD ABUSE; CITALOPRAM; COMORBIDITY; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIANSERIN; MIDDLE AGED; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RECURRENCE; SELF REPORT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875936452     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291712001742     Document Type: Article

References (56)

1. Alpert JE, Fava M, Uebelacker LA, Nierenberg AA, Pava JA, Worthington 3rd JJ, Rosenbaum JF (1999). Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder. Biological Psychiatry 46, 202-211.
2. Altman EG, Hedeker D, Peterson JL, Davis JM (1997). The Altman Self-Rating Mania Scale. Biological Psychiatry 42, 948-955.
3. Bernet CZ, Stein MB (1999). Relationship of childhood maltreatment to the onset and course of major depression in adulthood. Depression and Anxiety 9, 169-174.
4. Bernstein IH, Rush AJ, Carmody TJ, Woo A, Trivedi MH (2007). Clinical v. self-report versions of the Quick Inventory of Depressive Symptomatology in a public sector sample. Journal of Psychiatric Research 41, 239-246.
5. Blanco C, Vesga-López O, Stewart JW, Liu SM, Grant BF, Hasin DS (2012). Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Clinical Psychiatry 73, 224-232.
6. Calear AL, Christensen H (2010). Systematic review of school-based prevention and early intervention programs for depression. Journal of Adolescence 33, 429-438.
7. Fava M (2001). Augmentation and combination strategies in treatment-resistant depression. Journal of Clinical Psychiatry 62 (Suppl. 18), 4-11.
8. Fava M (2009). Augmentation and combination strategies for complicated depression. Journal of Clinical Psychiatry 70, e40.
9. Fava M, Alpert JE, Borus JS, Nierenberg AA, Pava JA, Rosenbaum JF (1996). Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. American Journal of Psychiatry 153, 1308-1312.
10. Frisch MB, Clark MP, Rouse SV, Rudd MD, Paweleck JK, Greenstone A, Kopplin DA (2005). Predictive and treatment validity of life satisfaction and the quality of life inventory. Assessment 12, 66-78.
11. Guerry JD, Hastings PD (2011). In search of HPA axis dysregulation in child and adolescent depression. Clinical Child and Family Psychology Review 14, 135-160.
12. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
13. Hammen C, Brennan PA, Keenan-Miller D, Herr NR (2008). Early onset recurrent subtype of adolescent depression: clinical and psychosocial correlates. Journal of Child Psychology and Psychiatry and Allied Disciplines 49, 433-440.
14. Harald B, Gordon P (2012). Meta-review of depressive subtyping models. Journal of Affective Disorders 139, 126-140.
15. Kaufman J, Martin A, King RA, Charney D (2001). Are child-, adolescent-, and adult-onset depression one and the same disorder? Biological Psychiatry 49, 980-1001.
16. Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 40, 762-772.
17. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, Ustun TB, Wang PS (2009). The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiologica Psichiatria Sociale 18, 23-33.
18. Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustun TB (2007). Age of onset of mental disorders: a review of recent literature. Current Opinion in Psychiatry 20, 359-364.
19. Klein DN, Arnow BA, Barkin JL, Dowling F, Kocsis JH, Leon AC, Manber R, Rothbaum BO, Trivedi MH, Wisniewski SR (2009). Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depression and Anxiety 26, 701-710.
20. Klein DN, Schatzberg AF, McCullough JP, Dowling F, Goodman D, Howland RH, Markowitz JC, Smith C, Thase ME, Rush AJ, LaVange L, Harrison WM, Keller MB (1999). Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. Journal of Affective Disorders 55, 149-157.
21. Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW (2008). An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. Journal of Psychiatric Practice 14, 271-280.
22. Levine J, Schooler NR (1992). General versus specific inquiry with SAFTEE. Journal of Clinical Psychopharmacology 12, 448.
23. McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ (2006). Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR&z.ast;D report. American Journal of Psychiatry 163, 1531-1541; quiz 1666.
24. Miller A (2007). Social neuroscience of child and adolescent depression. Brain and Cognition 65, 47-68.
25. Miniati M, Rucci P, Benvenuti A, Frank E, Buttenfield J, Giorgi G, Cassano GB (2010). Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse. Journal of Psychiatric Research 44, 302-309.
26. Mundt JC, Marks IM, Shear MK, Greist JH (2002). The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry 180, 461-464.
27. Papakostas GI (2009). Pharmacologic and therapeutic strategies in treatment-resistant depression. Switching antidepressants vs. conventional augmentation strategies. CNS Spectrums 14, 11-14.
28. Parker G, Roy K, Hadzi-Pavlovic D, Mitchell P, Wilhelm K (2003). Distinguishing early and late onset non-melancholic unipolar depression. Journal of Affective Disorders 74, 131-138.
29. Ramklint M, Ekselius L (2003). Personality traits and personality disorders in early onset versus late onset major depression. Journal of Affective Disorders 75, 35-42.
30. Rao U, Chen LA (2009). Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders. Dialogues in Clinical Neuroscience 11, 45-62.
31. Rao U, Weissman MM, Martin JA, Hammond RW (1993). Childhood depression and risk of suicide: a preliminary report of a longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry 32, 21-27.
32. Rush AJ (2007). The varied clinical presentations of major depressive disorder. Journal of Clinical Psychiatry 68 (Suppl. 8), 4-10.
33. Rush AJ, Carmody TJ, Ibrahim HM, Trivedi MH, Biggs MM, Shores-Wilson K, Crismon ML, Toprac MG, Kashner TM (2006). Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatric Services 57, 829-837.
34. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 54, 573-583.
35. Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR (2011). Combining Medications to Enhance Depression Outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. American Journal of Psychiatry 168, 689-701.
36. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003). The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis and Rheumatism 49, 156-163.
37. Scott MA, Wilcox HC, Schonfeld IS, Davies M, Hicks RC, Turner JB, Shaffer D (2009). School-based screening to identify at-risk students not already known to school professionals: the Columbia suicide screen. American Journal of Public Health 99, 334-339.
38. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 (Suppl. 20), 22-33; quiz 34-57.
39. Stewart JW, McGrath PJ, Fava M, Wisniewski SR, Zisook S, Cook I, Nierenberg AA, Trivedi MH, Balasubramani GK, Warden D, Lesser I, Rush A (2010). Do atypical features affect outcome in depressed outpatients treated with citalopram? International Journal of Neuropsychopharmacology 13, 15-30.
40. Taurines R, Gerlach M, Warnke A, Thome J, Wewetzer C (2011). Pharmacotherapy in depressed children and adolescents. World Journal of Biological Psychiatry 12 (Suppl. 1), 11-15.
41. Thompson AH (2008). Younger onset of depression is associated with greater suicidal intent. Social Psychiatry and Psychiatric Epidemiology 43, 538-544.
42. Trivedi MH, Daly EJ (2007). Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug and Alcohol Dependence 88 (Suppl. 2), S61-S71.
43. Trivedi MH, Morris DW, Pan JY, Grannemann BD, John Rush A (2005). What moderator characteristics are associated with better prognosis for depression? Neuropsychiatric Disease and Treatment 1, 51-57.
44. Trivedi MH, Rush AJ, Gaynes BN, Stewart JW, Wisniewski SR, Warden D, Ritz L, Luther JF, Stegman D, Deveaugh-Geiss J, Howland R (2007). Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(&z.ast;)D measurement-based care. Neuropsychopharmacology 32, 2479-2489.
45. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine 34, 73-82.
46. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR&z.ast;D: implications for clinical practice. American Journal of Psychiatry 163, 28-40.
47. Trivedi MH, Wisniewski SR, Morris DW, Fava M, Gollan JK, Warden D, Nierenberg AA, Gaynes BN, Husain MM, Luther JF, Zisook S, Rush AJ (2011). Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. Journal of Clinical Psychiatry 72, 757-764.
48. van Noorden MS, Minkenberg SE, Giltay EJ, den Hollander-Gijsman ME, van Rood YR, van der Wee NJ, Zitman FG (2011). Pre-adult versus adult onset major depressive disorder in a naturalistic patient sample: the Leiden Routine Outcome Monitoring Study. Psychological Medicine 41, 1407-1417.
49. WHO (2008). The Global Burden of Disease: 2004 Update. World Health Organization: Geneva, Switzerland.
50. Wisniewski SR, Eng H, Meloro L, Gatt R, Ritz L, Stegman D, Trivedi M, Biggs MM, Friedman E, Shores-Wilson K, Warden D, Bartolowits D, Martin JP, Rush AJ (2004). Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR&z.ast;D) project. Clinical Trials 1, 387-398.
51. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA (2006). Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice 12, 71-79.
52. Zimmerman M, Mattia JI (2001a). The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Comprehensive Psychiatry 42, 175-189.
53. Zimmerman M, Mattia JI (2001b). A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry 58, 787-794.
54. Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ (2007a). Effect of age at onset on the course of major depressive disorder. American Journal of Psychiatry 164, 1539-1546.
55. Zisook S, Rush AJ, Albala A, Alpert J, Balasubramani GK, Fava M, Husain M, Sackeim H, Trivedi M, Wisniewski S (2004). Factors that differentiate early vs. later onset of major depression disorder. Psychiatry Research 129, 127-140.
56. Zisook S, Rush AJ, Lesser I, Wisniewski SR, Trivedi M, Husain MM, Balasubramani GK, Alpert JE, Fava M (2007b). Preadult onset vs. adult onset of major depressive disorder: a replication study. Acta Psychiatrica Scandinavica 115, 196-205.